Clinical considerations in rodent bioimaging.

Comp Med 2004 Dec;54(6):623-30

Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0614, USA.

Imaging modalities such as micro-computed tomography (micro-CT), micro-positron emission tomography (micro-PET), high-resolution magnetic resonance imaging (MRI), optical imaging, and high-resolution ultrasound are rapidly becoming invaluable research tools. These advanced imaging technologies are now commonly used to investigate rodent biology, metabolism, pharmacokinetics, and disease in vivo. Choosing an appropriate anesthetic regimen as well as monitoring and supporting the animal's physiologic balance is key to obtaining images that truly represent the biologic process or disease state of interest. However, there are many challenges in rodent bioimaging such as limited animal access, small sample volumes, anesthetic complications, strain and gender variability, and the introduction of image artifacts. Because each imaging study presents unique challenges, a thorough understanding of the imaging modality used, the animal's health status, and the research data desired is required. This article addresses these issues along with other common laboratory animal clinical considerations such as biosecurity and radiation safety in in vivo rodent bioimaging.

Download full-text PDF

December 2004

Similar Publications

Imaging tumour-bearing animals using clinical scanners.

Int J Radiat Biol 2009 Sep;85(9):752-62

OncoRay, Medical Faculty Carl Gustav Carus, University of Technology-Dresden, Fetscherstrasse 74, Dresden, Germany.

Purpose: We investigated the capability of small animal imaging in clinical scanners for cancer research focusing on positron emission tomography (PET), computed tomography (CT) and magnetic resonance imaging (MRI).

Methods And Materials: We summarise basic principles, benefits and drawbacks of imaging modalities and discuss issues associated with animal welfare during imaging and its related effects on imaging results based on data from literature supplemented by own experiences.

Results: MRI of tumour-bearing mice and rats in the clinical scanner is well-established for morphological and functional imaging in oncology. Read More

View Article and Full-Text PDF
September 2009

In vivo mouse imaging and spectroscopy in drug discovery.

NMR Biomed 2007 May;20(3):154-85

Discovery Technologies, Novartis Institutes for BioMedical Research, Lichtstrasse 35, CH-4002 Basel, Switzerland.

Imaging modalities such as micro-computed tomography (micro-CT), micro-positron emission tomography (micro-PET), high-resolution MRI, optical imaging, and high-resolution ultrasound have become invaluable tools in preclinical pharmaceutical research. They can be used to non-invasively investigate, in vivo, rodent biology and metabolism, disease models, and pharmacokinetics and pharmacodynamics of drugs. The advantages and limitations of each approach usually determine its application, and therefore a small-rodent imaging laboratory in a pharmaceutical environment should ideally provide access to several techniques. Read More

View Article and Full-Text PDF
May 2007

Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.

Acc Chem Res 2008 Dec;41(12):1630-40

Department of Chemistry, Yonsei University, Seoul 120-749, Korea.

Current biomedical imaging techniques including magnetic resonance imaging (MRI), positron emission tomography (PET), and computed X-ray tomography (CT) are vital in the diagnosis of various diseases. Each imaging modality has its own merits and disadvantages, and a single technique does not possess all the required capabilities for comprehensive imaging. Therefore, multimodal imaging methods are quickly becoming important tools for state-of-the-art biomedical research and clinical diagnostics and therapeutics. Read More

View Article and Full-Text PDF
December 2008

Advanced imaging for veterinary cancer patients.

Vet Clin North Am Small Anim Pract 2007 Nov;37(6):1059-77; v-i

Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, C247 Veterinary Teaching Hospital, Knoxville, TN 37996-4544, USA.

This article presents an update on the recent advances made in veterinary advanced imaging specifically with regard to cross-sectional modalities (CT and MRI) and nuclear medicine (positron emission tomography [PET] and PET/CT). A brief summary of technical improvements and a review of recent literature are included to provide an overview of the progress made in this important element of the practicing veterinary oncologist's repertoire. An in-depth summary of PET is also included to introduce the technical aspects and potential clinical and research applications of this novel imaging modality in veterinary medicine. Read More

View Article and Full-Text PDF
November 2007